Bright Minds Biosciences Inc.DRUGNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank83
3Y CAGR+94.8%
5Y CAGR+81.1%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+94.8%/yr
Annual compound
5Y CAGR
+81.1%/yr
Recent acceleration
Percentile
P83
Within normal range
vs 5Y Ago
19.5x
Strong expansion
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 77.47% |
| 2024 | -34.29% |
| 2023 | -13.77% |
| 2022 | 10.48% |
| 2021 | 1916.60% |
| 2020 | 3.98% |
| 2019 | 0.00% |